MedTrace Logo

A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects

NCT00374881 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2008-04-15

No results posted yet for this study

Summary

Efficacy and Safety of the combined oral adjuvants phenylephrine and sorbitol on oral low dose morphine analgesia.

Conditions

  • Acute Pain

Interventions

DRUG

Morphine

Morphine

DRUG

Morphine

Morphine low dose

DRUG

Sorbitol+Phenylephrine

Sorbitol+Phenylephrine

DRUG

Sorbitol+Phenylephrine+Morphine

Sorbitol+Phenylephrine+Morphine

DRUG

Sorbitol low concentration+Phenylephrine+Morphine

Sorbitol low concentration+Phenylephrine+Morphine

Sponsors & Collaborators

  • BioLineRx, Ltd.

    lead INDUSTRY

Principal Investigators

  • Yehuda Ginosar, Bsc, MBBS · Department of Anesthesiology, Hadassah Hebrew University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2007-06-30
Completion
2007-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00374881 on ClinicalTrials.gov